In March 2011, Fujifilm Corporation bought all equity interests of the Merck BioManufacturing Network from Merck & Co., Inc (“Merck”). The new name for the Merck BioManufacturing Network is “Fujifilm Diosynth Biotechnologies.” The formation  of Fujifilm Diosynth Biotechnologies (FDB) is part of Fujifilm’s strategy to enter the life sciences market. Through FDB, Fujifilm looks to be a leader in the biopharmaceutical contract manufacturing market.    History Merck Biomanufacturing Ne...